Appropriations Full Committee
Recent Activity
Displaying 71 - 75 of 217
During today’s House Appropriations subcommittee markup of the 2026 Defense funding bill, House Democrats highlighted how the bill undermines democracy at home and abroad and includes harmful policy riders that divide our nation.
Congresswoman Rosa DeLauro (D-CT-03), Ranking Member of the House Appropriations Committee, delivered the following remarks at the subcommittee markup of the 2026 Defense funding bill:
– As Prepared for Delivery –
Thank you, Mr. Chairman for yielding.
And I thank you and the Ranking Member, and the subcommittee staff on both sides of the aisle for their work on this bill in particular, Jennifer Chartrand, Jason Gray, and Ed Etzkorn.
This subcommittee has the grave and solemn responsibility of appropriating the funds necessary to defend and protect our nation, and to protect the safety and well-being of our men and women in uniform.
WASHINGTON — Congressman James E. Clyburn (D-SC-06), Ranking Member of the Transportation, and Housing and Urban Development, and Related Agencies Subcommittee, delivered the following remarks at the subcommittee's fiscal year 2026 budget hearing for the Department of Housing and Urban Development:
Congresswoman Betty McCollum (D-MN-04), Ranking Member of the Defense Appropriations Subcommittee, delivered the following remarks at the subcommittee markup of the 2026 Defense funding bill:
Washington, D.C. — Congresswoman Rosa DeLauro (D-CT-03), Ranking Member of the House Appropriations Committee and the Labor, Health and Human Services, Education, and Related Agencies Subcommittee, Senator Patty Murray (D-WA), Senate Appropriations Committee Vice Chair, and Senator Tammy Baldwin (D-WI), Ranking Member of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, sent a letter to National Institutes of Health (NIH) Director Dr. Jayanta Bhattacharya calling out the Trump administration’s reckless decision to terminate at least 2,370 active NIH grants, an illegal move that has upended biomedical research and threatened patients’ access to treatment, and demanding that NIH provide the House and Senate Committees on Appropriations the legal authority being used to terminate grants, a comprehensive list of grant cancellations, details on the impact to clinical trials, and the criteria used for termination decisions.